ESLA
Estrella Immunopharma Inc.
NASDAQ: ESLA · HEALTHCARE · BIOTECHNOLOGY
$1.64
+11.56% today
Updated 2026-04-30
Market cap
$67.41M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.35
Dividend yield
—
52W range
$1 – $3
Volume
0.1M
Estrella Immunopharma Inc. (ESLA) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |